jCyte is a clinical-stage company focused on the application of progenitor cell-based technology in retinal diseases. The Company's allogeneic product candidate, jCell, is delivered by simple intravitreal injection without the need for surgery or immune suppression. jCyte has completed a phase 1/2a, phase 1/2a extension and phase 2b clinical trials testing jCell in patients with Retinitis Pigmentosa.
View Top Employees from jCyte, Inc.| Website | http://www.jcyte.com/ |
| Revenue | $1 million |
| Employees | 11 (9 on RocketReach) |
| Founded | 2012 |
| Address | 23 Corporate Plaza Dr Suite 150, Newport Beach, California 92660, US |
| Phone | (949) 824-3990 |
| Technologies |
JavaScript,
HTML,
Google Analytics
+8 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Drug Discovery, Business Services, Science and Engineering, Health Care, Information Technology, Software |
| Competitors | DiscGenics, InGeneron, Ixion Biotechnology Inc, Minerva Biotechnologies, Regeneus Ltd |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies |
Looking for a particular jCyte, Inc. employee's phone or email?
jCyte, Inc. Questions
The jCyte, Inc. annual revenue was $1 million in 2024.
John Sholar is the CEO of jCyte, Inc..
9 people are employed at jCyte, Inc..
jCyte, Inc. is based in Newport Beach, California.
The NAICS codes for jCyte, Inc. are [54, 5417, 54171, 541714, 541].
The SIC codes for jCyte, Inc. are [87, 873].
Top jCyte, Inc. Employees
-
31
-
ViewVictor Chao
Vice President Commercial Strategy and Operations at jCyte, Inc.
San Francisco, California, United States55+ -
34
-
43
-
21
-
11
-
43
-
1
Related Companies
